HEPHAISTOS-Pharma

HEPHAISTOS-Pharma is a biotechnology company developing next-generation immunotherapies against cancer. Their lead candidate, ONCO-Boost, stimulates the patient's immune system to increase responses against tumors, working both as a single agent and in combination with other therapies. ONCO-Boost is the first immunostimulant to demonstrate efficacy against primary tumors and metastases.

Buy Funded Startups lists

Funding Round: Seed

Funding Amount: €4.3M

Date: 16-May-2024

Investors: Elaia, xista science ventures, Fondation Fournier-Majoie, Noshaq

Markets: Biotechnology, Oncology, Immunotherapy

HQ: Orsay, Île-de-France, France

Founded: 2018

Website: https://www.hephaistos-pharma.com/

LinkedIn: https://fr.linkedin.com/company/hephaistos-pharma

Twitter:

Instagram: